A new clinical genomics lab at
Milan's European Oncology Institute (IEO) will kick off by
running a new test able to map a genetic cancer risk by
analysing 115 hereditary genetic mutations of all kinds, sources
said Wednesday. The test will be carried out free for a year on
ovarian cancer patients, IEO scientific director Roberto
Orecchia said. IEO research chief Piergiuseppe Pelicci said that
"among the advantages is to be able to better identify the
individual risk, set up personalised protection paths, to be
able to identify a greater number of hereditary cancers, and to
seek preventive molecular drugs which combat them".
ALL RIGHTS RESERVED © Copyright ANSA
